Antimicrobial synergy between carprofen and doxycycline against methicillin-resistant Staphylococcus pseudintermedius ST71

BMC Veterinary Research

Volumn 12, Issue 1, 2016, Pages

  Brochmann, Rikke Prejh ^a   Helmfrid, Alexandra ^a   Jana, Bimal ^a   Magnowska, Zofia ^a   Guardabassi, Luca ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b ROSS UNIVERSITY SCHOOL OF VETERINARY MEDICINE   (Saint Kitts and Nevis)

Author keywords

Dogs; Multidrug resistance; Non steroidal anti inflammatory drugs; Veterinary antimicrobial therapy

Indexed keywords

ANTIINFECTIVE AGENT; CARBAZOLE DERIVATIVE; CARPROFEN; DOXYCYCLINE;

DISK DIFFUSION; DRUG EFFECTS; DRUG POTENTIATION; GENETICS; PENICILLIN RESISTANCE; STAPHYLOCOCCUS;

ANTI-BACTERIAL AGENTS; CARBAZOLES; DISK DIFFUSION ANTIMICROBIAL TESTS; DOXYCYCLINE; DRUG SYNERGISM; METHICILLIN RESISTANCE; STAPHYLOCOCCUS;

EID: 84975745780     PISSN: None     EISSN: 17466148     Source Type: Journal    
DOI: 10.1186/s12917-016-0751-3     Document Type: Article

References (26)

1. Guardabassi L, Larsen J, Weese JS, Butaye P, Battisti A, Kluytmans J, Lloyd DH, Skov RL. Public health impact and antimicrobial selection of meticillin-resistant staphylococci in animals. J Glob Antimicrob Resist. 2013;1(2):55-62.
2. Perreten V, Kadlec K, Schwarz S, Gronlund Andersson U, Finn M, Greko C, Moodley A, Kania SA, Frank LA, Bemis DA et al. Clonal spread of methicillin-resistant Staphylococcus pseudintermedius in Europe and North America: an international multicentre study. J Antimicrob Chemother. 2010;65(6):1145-54.
3. Soothill G, Hu Y, Coates A. Can we prevent antimicrobial resistance by using antimicrobials better? PLoS Pathog. 2013;2(2):422-35.
4. Worthington RJ, Melander C. Combination approaches to combat multidrug-resistant bacteria. Trends Biotechnol. 2013;31(3):177-84.
5. Cederlund H, Mårdh PA. Antibacterial activities of non-antibiotic drugs. J Antimicrob Chemother. 1993;32(3):355-65.
6. De Briyne N, Atkinson J, Pokludová L, Borriello SP. Antibiotics used most commonly to treat animals in Europe. Vet Rec. 2014;175(13):327-35.
7. Clinical and Laboratory Standards Institute (CLSI), Wayne PA. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Third Informational Supplement M100-S23. Wayne: CLSI; 2013. p. 1-199.
8. Frazier DL, Thompson L, Trettien A, Evans EI. Comparison of fluoroquinolone pharmacokinetic parameters after treatment with marbofloxacin, enrofloxacin, and difloxacin in dogs. J Vet Pharmacol Ther. 2000;23(5):293-302.
9. Dupont N, Stege H. Vetstat-monitoring usage of antimicrobials in animals. In: Egger-Danner C, Hansen O, Stock K, Pryce J, Cole J, Gengler N, Heringstad B, editors. International Committee for Animal Recording (ICAR) Technical Series. 2013. p. 21-35.
10. Moody J. Clinical microbiology procedures handbook. In: Garcia L, editor. Synergism testing: broth microdilution checkerboard and broth macrodilution methods. ASM Press; 2010. p. 5.12. 11-15.12. 23.
11. Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother. 2003;52(1):1.
12. Maaland MG, Papich MG, Turnidge J, Guardabassi L. Pharmacodynamics of doxycycline and tetracycline against Staphylococcus pseudintermedius: proposal of canine-specific breakpoints for doxycycline. J Clin Microbiol. 2013;51(11):3547-54.
13. McKellar QA, Pearson T, Bogan JA, Gaibraith EA, Lees P, Ludwig B, Tiberghien MP. Pharmacokinetics, tolerance and serum thromboxane inhibition of carprofen in the dog. J Small Anim Pract. 1990;31(9):443-8.
14. Sud I, Feingold DS. Action of antifungal imidazoles on Staphylococcus aureus. Antimicrob Agents Chemother. 1982;22(3):470-4.
15. Cutsem JV, Gerven FV, Cauwenbergh G, Odds F, Janssen PAJ. The antiinflammatory effects of ketoconazole: a comparative study with hydrocortisone acetate in a model using living and killed Staphylococcus aureus on the skin of guinea pigs. J Am Acad Dermatol. 1991;25(2, Part 1):257-61.
16. Grange JM, Snell NJC. Activity of bromhexine and ambroxol, semi-synthetic derivatives of vasicine from the Indian shrub Adhatoda vasica, against Mycobacterium tuberculosis in vitro. J Ethnopharmacol. 1996;50(1):49-53.
17. Munoz-Bellido JL, Munoz-Criado S, Garcìa-Rodrìguez JA. Antimicrobial activity of psychotropic drugs: selective serotonin reuptake inhibitors. Int J Antimicrob Agents. 2000;14(3):177-80.
18. Kruszewska H, Zareba T, Tyski S. Estimation of antimicrobial activity of selected non-antibiotic products. Acta Pol Pharm. 2006;63:457-60.
19. Mandal A, Sinha C, Jena AK, Ghosh S, Samanta A. An investigation on in vitro and in vivo antimicrobial properties of the antidepressant: amitriptyline hydrochloride. Braz J Microbiol. 2010;41(3):635-45.
20. Yin Z, Wang Y, Whittell LR, Jergic S, Liu M, Harry E, Dixon NE, Kelso MJ, Beck JL, Oakley AJ. DNA replication is the target for the antibacterial effects of nonsteroidal anti-inflammatory drugs. Chem Biol. 2014;21(4):481-7.
21. Elitok B, Elitok ÖM. Clinical efficacy of carprofen as an adjunct to the antibacterial treatment of bovine respiratory disease. J Vet Pharmacol Ther. 2004;27(5):317-20.
22. Cakir Y, Hahn K. Direct action by doxycycline against canine osteosarcoma cell proliferation and collagenase (MMP-1) activity in vitro. In vivo (Athens, Greece). 1998;13(4):327-31.
23. Guardabassi L, Houser GA, Frank LA, Papich MG. Guidelines for antimicrobial use in dogs and cats. In: Guide to antimicrobial use in animals. 2008. p. 183-206.
24. Brentnall C, Cheng Z, McKellar QA, Lees P. Influence of oxytetracycline on carprofen pharmacodynamics and pharmacokinetics in calves. J Vet Pharmacol Ther. 2013;36(4):320-8.
25. Sapadin AN, Fleischmajer R. Tetracyclines: non-antibiotic properties and their clinical implications. J Am Acad Dermatol. 2006;54(2):258-65.
26. Ejim L, Farha MA, Falconer SB, Wildenhain J, Coombes BK, Tyers M, Brown ED, Wright GD. Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy. Nat Chem Biol. 2011;7(6):348-50.